Research has shown that inhibition or genetic knockout of FABP5 has anti‐nociceptive effects in several models of pain, including inflammatory pain, osteoarthritis and chronic constriction injury (Berger et al., 2012; Bogdan et al., 2018, 2022; Fauzan et al., 2022; Gordon et al., 2024; Kaczocha et al., 2014, 2015; Peng et al., 2017; Yan et al., 2018; Zhu et al., 2023). The gene discussed is FABP5; the disease is osteoarthritis.